$AZN

AI 分析

生成於 May 11, 2026

AI Score
76/ 100
Buy$AZN

AstraZeneca PLC

$AZNNASDAQHealthcareMega-Cap

AstraZeneca develops prescription medicines in oncology, cardiovascular, renal, respiratory, and immunology.

Market Cap
$220.0B
Revenue (TTM)
$49.0B
+8.0%
Net Income (TTM)
$6.5B
+12.0%
EPS (TTM)
$4.20
P/E Ratio
35.0
Dividend Yield
2.0%
52-Week Range
$58-$87
Beta
0.52
Dimension Scores
Fundamental
78
Technical
68
Sentiment
74
Risk / Reward
76
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
83strong
Growth
71moderate
Liquidity
84strong
Solvency
80strong
Efficiency
76strong

Valuation, technical analysis, investment thesis, risk assessment and more for $AZN

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。